LHC — Q4 2020 Earnings Presentation
47 slides from LHC's earnings presentation, Feb 26, 2021
Slide 1: Supplemental Financial Information Fourth Quarter Ended December 31, 2020
Supplemental Financial Information Fourth Quarter Ended December 31, 2020 February 25, 2021 Exhibit 99.2
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains “forward-looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company. Words such as “anticipate,” “expect,” “project,” “intend,”
Slide 3: Table of Contents
Table of Contents 3 Overview & Policy Tailwinds 4 - 8 Differentiated Strategies 9 - 20 Full Year & Fourth Quarter Consolidated Results Adjusted Segment Results Guidance, Liquidity & Outlook Appendix LHC Group Overview Commentary on Q4 and FY 2020 At Home Care Policy Tailwinds Differentiated Strategy
Slide 4: Overview & Policy Tailwinds
4 Overview & Policy Tailwinds
Slide 5: LHC Group Overview
Home Health Hospice HCBS Home Health & Hospice Home Health & HCBS Home Health, Hospice, & HCBS LHC Group Overview 5 537 home health locations 60% Of U.S. population aged 65+ included in service area 120 hospice locations 124 home & community based services locations 12 Long term acute care hospitals
Slide 6: Commentary on Q4 and FY 2020
Organic growth in admissions for home health locations increased 2.2% for the quarter compared to the same period in 2019 with 1.0% same store sequential growth over the third quarter of 2020. Our non-Medicare episodic same store admissions have grown 28.7% in Q4 as compared to Q4 in 2019. The major
Slide 7: At Home Care Policy Tailwinds
Each year Congress publishes reports with an enacted federal budget explaining appropriations including those for the Departments of Labor and HHS. This report language is how Congress directs appropriations, commands reports and investigations, speaks to agencies that spend money, and protects cons
Slide 8: Appropriation Committee Report Summary
Relevant sections of the Appropriation Committee Report are summarized below referencing report pages and quotes of interest. Rural Patient Access to Home Health Care - "Home Health Payment Systems - The Committee urges CMS to avoid home health payment systems that would risk patient access to home
Slide 9: Differentiated Strategies
9 Differentiated Strategies
Slide 10: Differentiated Strategy Leading to Quality Growth
Joint ventures drive organic growth and margin improvement Same store growth for JV locations averaged 200 basis points higher than non-JV locations for the years 2016-2019. Revenue growth rate for JVs average 10% to 15% in year 2 and 3. Margins for JV locations average 100 to 200 basis points highe
Slide 11: Multiple Organic and Inorganic Growth Levers
Multiple Organic and Inorganic Growth Levers Organic Growth Acquisition Growth Upside Opportunities Move to taking risk on total cost of HH from MA plans and health systems Grow Imperium ACOs and extend proven record of managing post-acute network building Create high performing post-acute networks
Slide 12: Building Blocks of Long-Term Earnings Growth
Building Blocks of Long-Term Earnings Growth Developing alternative reimbursement models (PMPM; Case Rate; episodic) with regional and national payors, demonstrating continued progression beyond fee-for-service and per visit relationships Revising contracts and developing processes with major payors
Slide 13: Hospice Growth 2016 - 2020
Hospice Growth 2016 - 2020 aus ae mowth M20 at maura 2 venue $12,847 $357208 § 25709 MASS amaiH 4 stam a6eaN SaaEeRD $ argON ass 2engOe 5 sea cotocatons “ ee ee a3
Slide 14: Sequential Operational Trends Continue to Improve
Sequential Operational Trends Continue to Improve 14 Home Health, Hospice and HCBS Trends
Slide 15: Home Health and Hospice Organic Growth in 2020
15 Home Health and Hospice Organic Growth in 2020 Same Store Organic Admission Growth by 2020 Period over Same Period in 2019
Slide 16: Swift, Comprehensive Approach to COVID-19
Rigorous clinical protocols and a long history of treating infectious diseases have ensured LHC Group’s ability to fill a crucial role throughout this crisis Daily employee screenings in the field and all locations based on CDC guidelines; patients seen by clinicians with at least face mask and glov
Slide 17: New Physician Home Health Referral Sources
17 New Physician Home Health Referral Sources
Slide 18: Industry-Leading Quality and Patient Satisfaction
Industry-Leading Quality and Patient Satisfaction 85% of LHC Group same-store providers have CMS 4 stars or greater for quality 18 100% of LHC Group home health and hospice agencies are Joint Commission accredited or are in the accreditation process within 12 to 18 months after acquisition. Approxim
Slide 19: Acquisitions and Joint Ventures in 2020
Acquisitions and Joint Ventures in 2020 19
Slide 20: Incremental Growth on Acquired Revenue from 2017 - 2019
Incremental Growth on Acquired Revenue from 2017 - 2019 20 Acquired Revenue from 2017 – 2019 = $313.2M excluding Almost Family acquisition in 2018. 2021 Estimated Revenue = $370.6M Acquired Contribution Margin from 2017 – 2019 = $13.5M excluding Almost Family acquisition in 2018. 2021 Estimated Cont
Slide 21: Full Year & Fourth Quarter Consolidated Results
21 Full Year & Fourth Quarter Consolidated Results
Slide 22: 2020 Adjusted Consolidated Results
2020 Adjusted Consolidated Results 22
Slide 23: Adjusted Consolidated Results – 2020 vs 2019
Adjusted Consolidated Results – 2020 vs 2019 23
Slide 24: Adjustments to Net Income
Adjustments to Net Income 24 *See footnotes on page 25
Slide 25: Adjustments to Net Income per Diluted Share
Adjustments to Net Income per Diluted Share 25
Slide 26: Segment Results
26 Segment Results
Slide 27: Three Months Ended Dec. 31, 2020 Adjusted Segment Results
27 Three Months Ended Dec. 31, 2020 Adjusted Segment Results
Slide 28: Twelve Months Ended Dec. 31, 2020 Adjusted Segment Results
28 Twelve Months Ended Dec. 31, 2020 Adjusted Segment Results
Slide 29: Home Health Segment Adjusted Segment Results – 2020 vs 19
29 Home Health Segment Adjusted Segment Results – 2020 vs 2019 Home Health Adjusted EBITDA margin improved 240 basis points in the fourth quarter of 2020 compared to the same period in 2019. Gross margin improved 590 basis points due to cost initiatives related to PDGM and a reduction in visits and
Slide 30: Home Health Revenue Factors
30 Home Health Revenue Factors The first 30-day period in an episode is referred to as P1 or Period 1. All other subsequent 30-day periods are referred to as P2. P1 is considered an early episode and receives a higher payment than a P2. Revenue per completed Medicare episode
Slide 31: Hospice Segment Adjusted Segment Results – 2020 vs 2019
31 Hospice Segment Adjusted Segment Results – 2020 vs 2019 Hospice Adjusted EBITDA margin improved 400 basis points in the fourth quarter of 2020 compared to the same period in 2019. Gross margin improved 290 basis points and general and administrative expense as a percent of revenue improved 120 ba
Slide 32: Home and Community Based Services Segment Adjusted Results
32 Home and Community Based Services Segment Adjusted Segment Results – 2020 vs 2019 Home and Community-Based Services Adjusted EBITDA margin improved 290 basis points in the fourth quarter of 2020 compared to the same period in 2019. The improvement was due to improvement in certain state Medicaid
Slide 33: Facility-Based Services Segment Adjusted Segment Results
Facility-Based Services Segment Adjusted Segment Results – 2020 vs 2019 33 Facility-Based Adjusted EBITDA margin improved 760 basis points in the fourth quarter of 2020 compared to the same period in 2019 due to an increase of 7.5% in patient days and higher revenue per patient day associated with t
Slide 34: Healthcare Innovations Segment Adjusted Segment Results
Healthcare Innovations Segment Adjusted Segment Results – 2020 vs 2019 34 Healthcare Innovations Adjusted EBITDA improved 174% in the twelve months ended December 31, 2020 compared to the same period in 2019 due to an increase of $6.7 million in Imperium’s Medicare Shared Savings Payment received in
Slide 35: Guidance, Liquidity & Outlook
35 Guidance, Liquidity & Outlook
Slide 36: Full Year 2021 Guidance Assumptions
Assumptions Estimated effective tax rate of 26.0% to 26.5% for full year 2021 and effective tax rate of 23.0% to 23.5% for the first quarter of 2021 due to the impact of an excess tax benefit related to the vesting of restricted stock. 8% to 10% organic growth in home health admissions for the year.
Slide 37: First Quarter 2021 Guidance
Assumptions Estimated effective tax rate of 23% to 23.5% for the first quarter of 2021 due to impact of an excess tax benefit related to the vesting of restricted stock. Increase in payroll taxes of approximately $6 million over Q4 2020. See bridge and trends from the fourth quarter 2020 to the firs
Slide 38: Bridge from Q4 2020 to Q2 2021
Bridge from Q4 2020 to Q2 2021 (see assumptions on slide 39) 38 Q4 2020 COVID Quarantine Winter Weather Closures Q1 2021 midpoint Sequestration Returns PHE Expires April 20 Home Health Growth Hospice Growth HCBS Growth Q2 2021 Q4 2020 Payroll tax Increase COVID Quarantine Winter Weather Closures Q1
Slide 39: Bridge from Q4 2020 to Q2 2021 Growth Assumptions
Bridge from Q4 2020 to Q2 2021 39 Bridge Growth Assumptions from Q1 2021 to Q2 2021 Home Health average census assumed for the first quarter of 2021 is approximately 84,000. Home Health average census to achieve the second quarter of 2021 bridge growth is approximately 87,500. On February 23, 2021,
Slide 40: First Quarter 2021 Home Health Trend
First Quarter 2021 Home Health Trend 40 Home Health average weekly census declined to a low 80,301 during the week ended January 9, 2021 as the percentage of clinicians quarantined increased from an average of approximately 1% in both Q2 and Q3 2020 to 4.1% during the week ending January 2nd, exacer
Slide 41: Debt and Liquidity Metrics
Debt and Liquidity Metrics 41
Slide 42: Focus for 2021
Focus for 2021 42 Maintain disciplined capital allocation with new joint ventures and other M&A activity. Accelerate unlocking the potential of our co-location and tri-location strategies. Maintain proactive posture to COVID-19 pandemic response. Continue to be a leader in the industry in quality an
Slide 43: Appendix
43 Appendix
Slide 44: Episodic Revenue Key Stats for Trailing 5 Quarters
Episodic Revenue Key Stats for Trailing 5 Quarters 44
Slide 45: Non-GAAP Reconciliations
Non-GAAP Reconciliations (Amounts in thousands, unaudited) 45 Footnotes are on page 32
Slide 46: Non-GAAP Reconciliations: Adjusted EBITDA
Non-GAAP Reconciliations (Amounts in thousands, unaudited) 46 Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
Slide 47: Slide 47